Related Experiment Video

Updated: May 19, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

K-J Kim1, S-M Moon, S-A Kim

  • 1Department of Pathology, School of Dentistry, Chosun University, Gwangju, Republic of Korea.

Oncogene
|August 22, 2012
PubMed

Insights

The HOXC6 gene promotes cancer drug resistance by upregulating MDR-1, a key transporter. Inhibiting HOXC6 increases cancer cells' sensitivity to chemotherapy, offering a potential therapeutic target for overcoming multidrug resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Pharmacology

Background:

  • Multidrug resistance (MDR) is a major obstacle in cancer chemotherapy.
  • Cellular expression of multidrug-efflux transporters is linked to MDR.
  • The role of HOXC6 in MDR regulation is not well understood.

Purpose of the Study:

  • To investigate the role of HOXC6 in regulating MDR to chemotherapeutic drugs.
  • To identify the molecular mechanisms by which HOXC6 influences MDR.

Main Methods:

  • Gene expression analysis comparing drug-resistant and parental cell lines.
  • Transfection assays to assess HOXC6's effect on MDR-1 promoter activity.
  • Small interfering RNA (siRNA) to inhibit HOXC6 expression.
  • Flow cytometry to analyze apoptosis and drug accumulation.

Main Results:

  • HOXC6 was overexpressed in drug-resistant cells.
  • HOXC6 activated the MDR-1 promoter, particularly at the TAAT motif (-2243 bp).
  • HOXC6 overexpression upregulated MDR-1, while HOXC6 inhibition repressed it.
  • Knockdown of HOXC6 increased sensitivity to paclitaxel and promoted apoptosis.

Conclusions:

  • HOXC6 is a key regulator of MDR in cancer cells.
  • HOXC6 promotes chemotherapeutic drug resistance through MDR-1.
  • Targeting HOXC6 may be a strategy to overcome MDR and enhance cancer treatment efficacy.

More Related Videos

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...